Inaugural Psychiatry Summit 2022

Access the Event: An access link for preregistrants of this event will be emailed 24 hours in advance of the program from support@digitellinc.comIf you are preregistered and do not receive this email in your inbox, please check your spam folder. If you still need assistance in accessing the event, please contact CCO Customer Support

Click here to register now on the event website!.
(Registration closes on March 24, 2022, at 7:00 AM ET)
Summit registration rate: $199.

The inaugural Psychiatry Summit 2022 includes 3 full days of live, virtual, cutting-edge programs!  The summit sets the standard for timely, unbiased, evidence-based education from the world’s leading experts.

Join psychiatrists, NPs, PAs, and other healthcare professionals from around the world for this unique virtual opportunity to enhance knowledge and improve patient outcomes. Engage with US-based and international experts as they discuss the latest advances in the diagnosis and treatment of a wide range of psychiatric illnesses, debate controversies in the field, and share their clinical pearls. Earn up to 15 hours of CME/CE credit.

Agenda

Inaugural Psychiatry Summit
March 24 – 26, 2022
Live Virtual Webinar
Tentative Agenda
Please note: All times are ET

Day 1 - Thursday, March 24, 2022 

9:45 – 10:00 AM: Opening Remarks by Scientific Committee Member - Roger S. McIntyre, MD, FRCPC – University of Toronto

10:00 – 11:00 AM: Keynote Address - The Pursuit of Mental Health Equity by Patrick J. Kennedy – Former Congressman (D-RI)

-5 min break-

11:05 – 12:05 PM: Translating Novel MDD Treatment Principles into Practice – Samantha Meltzer-Brody, MD, MPH – UNC Center for Women’s Mood Disorders

-5 min break-

12:10 – 1:10 PM: Non-Accredited CE Educational Session

-25 min meal break-

1:35 – 2:35 PM: Advancing Patient Care in Bipolar Depression – Holly A. Swartz, MD – University of Pittsburgh

2:35 – 3:30 PM: Poster Hall

-5 min break-

3:35 – 4:35 PM: Why Do Schizophrenia Patients Relapse and What Should We Do? – John M. Kane, MD – Hofstra/Northwell

-5 min break-

4:40 – 5:40 PM: New Mechanisms-New Medications for Schizophrenia: Jonathan M. Meyer, MD – University of California, San Diego 

5:40 – 5:50 PM: Closing Remarks by Scientific Committee Member – John M. Kane, MD – Hofstra/Northwell

 

Day 2 - Friday, March 25, 2022

9:45 – 10:00 AM: Opening Remarks by Scientific Committee Member – Alan F. Schatzberg, MD – Stanford University School of Medicine

10:00 – 11:00 AM: Pharmacological Strategies for Treatment-Resistant Depression – Siegfried Kasper, MD – Medical University of Vienna

-5 min break-

11:05 – 12:05 PM: Targeting Anxiety Symptoms in Mood Disorder Patients – Michael Thase, MD – University of Pennsylvania

-5 min break-

12:10 – 1:10 PM: Myth Busting in Psychopharmacology – Leslie Citrome, MD – New  York Medical College

-25 min break-

1:35 – 2:35 PM: Potential Drugs of Abuse as Antidepressants? – Alan F. Schatzberg, MD – Stanford University School of Medicine

2:35 – 3:30 PM: Poster Hall

-5 min break-

3:35 – 4:35 PM: Treatment of Bipolar-Unipolar as a Spectrum Disorder – Joseph Goldberg, MD – Mt. Sinai New York

-5 min break-

4:40 – 5:40 PM: A Bold Panoramic Grasp of Tardive Dyskinesia

-5 min break-

5:40 – 5:50 PM: Closing Remarks by Scientific Committee Member – Joseph Goldberg, MD – Mt. Sinai New York

 

Day 3 - Saturday, March 26, 2022

9:45 – 10:00 AM: Opening Remarks by Scientific Committee Member – Manpreet K. Singh, MD, MS – Stanford University  

10:00 – 11:00 AM: Fireside Chat: Mood Disorders in Special Populations – Manpreet K. Singh, MD, MS – Stanford University and Thomas L. Schwartz, MD – SUNY Upstate Medical University

-5 min break-

11:05 – 12:05 PM: Managing Schizophrenia Patients with Cardiometabolic Risk and Comorbidities – Christoph Correll, MD – Hofstra Northwell School of Medicine

-5 min break-

12:10 – 1:10 PM: Digital Transformation in Mental Health – John Torous, MD, MBI – Harvard Medical School

-25 min meal break-

1:35 – 2:35 PM: Treatment Resistant Bipolar Disorders – Roger S. McIntyre, MD, FRCPC – University of Toronto

2:35 – 3:30 PM: Poster Hall

-5 min break-

3:35 – 4:35 PM: Targeting Attentional Complaints Across DSM-5 Categories: A Transdiagnostic Approach – Gregory W. Mattingly, MD – Washington University

4:35 – 4:45 PM: Closing Remarks by Scientific Committee Member – Roger S. McIntyre, MD, FRCPC

Events

Date / Time
Event Details

Faculty

Faculty
Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Faculty
Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine
The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
New York, New York
Professor of Child and Adolescent Psychiatry
Charité – Universitätsmedizin Berlin
Berlin, Germany

Faculty
Siegfried Kasper, MD

Professor of Psychiatry
Emeritus Chairman, 
Department of Psychiatry and Psychotherapy
Medical University of Vienna
Vienna, Austria

Faculty
Patrick J. Kennedy

Former Congressman (D-RI);
Founder, The Kennedy Forum;
Co-Founder, One Mind

Faculty
Greg W. Mattingly, MD

Associate Clinical Professor
Psychiatry
Washington University School of Medicine
St Louis, Missouri
President
St Charles Psychiatry Associates
St Charles, Missouri

Faculty
Samantha Meltzer-Brody, MD, MPH

Distinguished Professor and Chair
Department of Psychiatry
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Faculty
Jonathan M. Meyer, MD

Clinical Professor
Psychiatry
University of California, San Diego
La Jolla, California
Psychopharmacology Consultant
California Department of State Hospitals
Sacramento, California

Faculty
Thomas L. Schwartz, MD

Professor of Psychiatry and Director of Adult Psychiatric Clinical Services
SUNY Upstate Medical University

Faculty
Holly A. Swartz, MD

Professor
Department of Psychiatry
University of Pittsburgh School of Medicine
Director
Center for Advanced Psychotherapy
Western Psychiatric Hospital
Pittsburgh, Pennsylvania

Faculty
Michael E. Thase, MD

Professor of Psychiatry
Department of Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Faculty
John Torous, MD

Assistant Professor of Psychiatry
Division of Digital Psychiatry
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Scientific Committee
Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Department of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Scientific Committee
John M. Kane, MD

Vice President for Behavioral Health Services
Northwell Health
Chairman of Psychiatry
Zucker Hillside Hospital
Queens, New York
Chairman of Psychiatry
Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell
Hempstead, New York

Scientific Committee
Roger McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
Department of Psychiatry/Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
Department of Psychiatry
Toronto, Canada

Scientific Committee
Alan F. Schatzberg, MD

Kenneth T. Norris, Jr., Professor
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Scientific Committee
Manpreet K. Singh, MD, MS

Associate Professor and Akiko Yamazaki and Jerry Yang Faculty
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Program Overview
The primary purpose of this activity is to improve participants’ competence in addressing the most important and most current challenges in the treatment of psychiatric illness by providing a focused upate on recent advances and key issues.

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of psychiatric illness.

Target Audience
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Review and assess the latest advances in treatment options for your patients with psychiatric disorders
  • Develop individualized treatment strategies for optimal outcomes in your patients with complex psychiatric disorders
  • Discuss best practices and treatment guidelines to improve patient care

Accreditation

**Credit/Contact hours are subject to change**

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 15.0 AMA PRA Category 1 CreditsTM. Psysicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 15.0 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 15.0 contact hours (1.5 CEUs) of the Accreditation Council for Pharmacy Education. UAN will be specific to each topic.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 15.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 15.0 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC (CCO) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CCO maintains responsibility for this course. Social workers completing this course will receive 15.0 continuing education credits.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.